Abiopharma

🔍 Moomaw Scott (Executive)

Company: Liquidia Corp (LQDA)

Report Date: 2025-08-29

Detailed Transactions and Holdings:

• Acquired 1,875 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 225,946.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3
• Sold 692 shares of Common Stock at $29.05 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 225,254.00 | transaction_form_type: 4 | Footnotes: F6, F5, F4
• Sold 8,315 shares of Common Stock at $28.6224 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 216,939.00 | transaction_form_type: 4 | Footnotes: F7, F8, F4
• Sold 61,685 shares of Common Stock at $28.6224 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 155,254.00 | transaction_form_type: 4 | Footnotes: F7, F8, F4
• Sold 1,875 shares of Restricted Stock Units (Derivative)
  Date: 2025-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,750.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
• F2: On January 16, 2022, the Reporting Person was granted 37,500 RSUs with 25% vesting on February 28, 2023 and the remaining RSUs vesting ratably on a quarterly basis over three years thereafter. Of those RSUs, a total of 26,250 have vested as of the date of this Form 4.
• F3: Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,077 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 69,729 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 11,842 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
• F4: Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,077 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 69,729 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 3,527 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
• F5: These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 16, 2022.
• F6: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2022.
• F7: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 29, 2025.
• F8: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $28.06 to $29.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.